Evidence map›Paper›PMID 27558176›Full record

ArticleJournal of clinical microbiology2016

Rapid Antimicrobial Susceptibility Testing Using Forward Laser Light Scatter Technology.

Randall T Hayden, Lani K Clinton, Carolyn Hewitt, Terri Koyamatsu, Yilun Sun, Ginger Jamison, Rosalie Perkins, Li Tang, Stanley Pounds, Matthew J Bankowski

Open access · bronzeAbstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Modern Tools for Rapid Diagnostics of Antimicrobial Resistance.Frontiers in cellular and infection microbiology · 2020
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Randall T HaydenSt. Jude Children's Research Hospital, Department of Pathology, Memphis, Tennessee, USA randall.hayden@stjude.org.
Lani K ClintonPathology Residency Program, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, USA.
Carolyn HewittSt. Jude Children's Research Hospital, Department of Pathology, Memphis, Tennessee, USA.
Terri KoyamatsuDiagnostic Laboratory Services, Inc. (The Queen's Medical Center), Aiea, Hawaii, USA.
Yilun SunSt. Jude Children's Research Hospital, Department of Biostatisics, Memphis, Tennessee, USA.
Ginger JamisonSt. Jude Children's Research Hospital, Department of Pathology, Memphis, Tennessee, USA.
Rosalie PerkinsSt. Jude Children's Research Hospital, Department of Pathology, Memphis, Tennessee, USA.
Li TangSt. Jude Children's Research Hospital, Department of Biostatisics, Memphis, Tennessee, USA.
Stanley PoundsSt. Jude Children's Research Hospital, Department of Biostatisics, Memphis, Tennessee, USA.
Matthew J BankowskiDiagnostic Laboratory Services, Inc. (The Queen's Medical Center), Aiea, Hawaii, USA.
St. Jude Children's Research Hospital · USUniversity of Hawaiʻi at Mānoa · USQueen's Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The delayed reporting of antimicrobial susceptibility testing remains a limiting factor in clinical decision-making in the treatment of bacterial infection. This study evaluates the use of forward laser light scatter (FLLS) to measure bacterial growth for the early determination of antimicrobial susceptibility. Three isolates each (two clinical isolates and one reference strain) of Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa were tested in triplicate using two commercial antimicrobial testing systems, the Vitek2 and the MicroScan MIC panel, to challenge the BacterioScan FLLS. The BacterioScan FLLS showed a high degree of categorical concordance with the commercial methods. Pairwise comparison with each commercial system serving as a reference standard showed 88.9% agreement with MicroScan (two minor errors) and 72.2% agreement with Vitek (five minor errors). FLLS using the BacterioScan system shows promise as a novel method for the rapid and accurate determination of antimicrobial susceptibility.

Indexed as

LasersAnti-Bacterial AgentsDynamic Light ScatteringEscherichia coliHumansMicrobial Sensitivity TestsPilot ProjectsPseudomonas aeruginosaStaphylococcus aureusTime FactorsAnti-Bacterial Agents

Identifiers

PMID27558176
PMCPMC5078546
OpenAlexW2510286175

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.